NCT03459677 (B2S) is a NA clinical trial of Back2School in Anxiety Symptoms, sponsored by University of Aarhus.

Who is sponsoring NCT03459677?

NCT03459677 is sponsored by University of Aarhus.

What drugs are being tested in NCT03459677?

Interventions in NCT03459677: Back2School, Treatment As Usual.

What condition does NCT03459677 study?

NCT03459677 studies Anxiety Symptoms, Depressive Symptoms, Behavioral Problem, School Absenteeism.

Is NCT03459677 still recruiting?

NCT03459677 is currently completed. Last updated 15 March 2023.

Last reviewed 2023-03-15 · How we verify

NCT03459677: B2S

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Back2School - CBT Intervention for School Absenteeism

Completed NA Last updated 15 March 2023

What this trial tests

NA trial testing Back2School in Anxiety Symptoms in 155 participants. Completed in 1 December 2020.

Timeline

25 August 2017

Primary endpoint
1 December 2020

1 December 2020

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	155
Start date	25 August 2017
Primary completion	1 December 2020
Estimated completion	1 December 2020
Sites	1 location across Denmark

Drugs / interventions tested

Back2School
Treatment As Usual

Conditions studied

Anxiety Symptoms — all drugs for Anxiety Symptoms →
Depressive Symptoms — all drugs for Depressive Symptoms →
Behavioral Problem — all drugs for Behavioral Problem →
School Absenteeism — all drugs for School Absenteeism →

Sponsor

University of Aarhus

Who can join

Adults 7 to 18, any sex, with Anxiety Symptoms or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to examine the efficacy of a new psychological intervention, called Back2School, in helping youths with problematic school absenteeism to return to school. Furthermore, the study will examine how well this program fares against the treatment or interventions that are usually given to youths with school absenteeism (treatment as usual or TAU). Based on previous studies we hypothesize that the Back2School intervention will be better at improving levels of school attendance as compared with treatment as usual (TAU).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The Back2School modular cognitive behavioral intervention for youths with problematic school absenteeism: study protocol for a randomized controlled trial.
Thastum M, Johnsen DB, Silverman WK, Jeppesen P, et al · · 2019 · cited 9× · PMID 30621787 · DOI 10.1186/s13063-018-3124-3
The Effectiveness of Modular Transdiagnostic Cognitive Behavioral Therapy Versus Treatment as Usual for Youths Displaying School Attendance Problems: A Randomized Controlled Trial.
Johnsen DB, Lomholt JJ, Heyne D, Jensen MB, et al · · 2024 · cited 6× · PMID 38739306 · DOI 10.1007/s10802-024-01196-8
Sociodemographic and clinical characteristics of youths and parents seeking psychological treatment for school attendance problems.
Johnsen DB, Lomholt JJ, Heyne D, Jeppesen P, et al · · 2022 · cited 6× · PMID 35081106 · DOI 10.1371/journal.pone.0261449

Verify or expand the search:

Other trials of Back2School

Trials testing the same drug.

NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting

Other recruiting trials for Anxiety Symptoms

Currently open trials in the same condition.

NCT06625502 — Unmute's CARE Framework: A Novel Approach to Strengthen the Therapeutic Alliance and Reduce Treatment Disparities · NA · active not recruiting
NCT07055906 — Video-feedback Intervention to Promote Racial-Ethnic Socialization Competency (VIP-RACE) · NA · recruiting
NCT07006220 — Project COPE-Spain (Coping Options for Parent Empowerment) · NA · recruiting
NCT06828276 — Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants · NA · recruiting
NCT07466979 — Exer-WAPA Project: Physical Exercise on Women's Affective and Physical HeAlth · NA · active not recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03459677 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 15 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03459677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing